NetworkNewsBreaks

FridayMar 01, 2024 3:30 pm

NetworkNewsBreaks – Astrotech Corporation’s (NASDAQ: ASTC) Breakthrough TRACER 1000(TM) Designed to Outperform Currently Used IMS Detectors

Astrotech (NASDAQ: ASTC) is a mass spectrometry company that, through its wholly owned subsidiary 1st Detect, has developed and rolled out the breakthrough TRACER 1000(TM) Explosive Trace Detector (“ETD”). “The world’s first mass spectrometry-based ETD certified by the European Civil Aviation Conference (‘ECAC’), the TRACER 1000(TM) is designed to outperform the ETDs currently used at aviation checkpoints as well as borders, cargo facilities and other secured points around the world. It is powered by the Astrotech Mass Spectrometer (‘AMS’) Technology that is inexpensive, smaller and easier to use when compared to traditional mass spectrometers. The AMS Technology works under ultra-high…

Continue Reading

FridayMar 01, 2024 2:45 pm

NetworkNewsBreaks – Astiva Health Redefining the Standards of Personalized and Comprehensive Healthcare

Astiva Health, a leading healthcare provider that specializes in delivering personalized and comprehensive solutions to diverse communities, is one of the companies committed to providing robust and stable benefit offerings to a growing number of people looking for the best Medicare options. “In a space where a growing number of individuals are qualifying for Medicare, Astiva Health is differentiating itself as a fast-growing Medicare Advantage Prescription Drug (‘MAPD’) health plan focused on redefining the standards of personalized and comprehensive healthcare. As an indication of its success, Astiva recently reached a key milestone, surpassing the 10,000-member mark… Reaching the milestone –…

Continue Reading

FridayMar 01, 2024 2:06 pm

NetworkNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Committed to Developing Groundbreaking Therapies, Transformative Solutions

PaxMedica (NASDAQ: PXMD) is a clinical-stage biopharmaceutical company focused on the development of novel anti-purinergic therapies (“APTs”) for the treatment of autism spectrum disorder (“ASD”) and other serious conditions with intractable neurologic symptoms. The company is on a promising path to address unmet medical needs of ASD patients. “The prevalence of ASD in the United States has risen to approximately 1 in 36 children, according to the Centers for Disease Control and Prevention (‘CDC’). There are currently no approved pharmacologic treatments that target the causes and symptoms of ASD – the treatment available on the market addresses symptoms of the…

Continue Reading

FridayMar 01, 2024 1:55 pm

NetworkNewsBreaks — SenesTech Inc.’s (NASDAQ: SNES) ContraPest(R) Delivers Significant Benefits in Efficacy Studies

SenesTech (NASDAQ: SNES), an animal pest control innovator, created its own unique niche within the pest control market after introducing its non-lethal liquid ContraPest(R) bait. “Instead of poisoning rats, the bait targets fertility reduction in male and female rats, and Evolve(TM) has a similar mechanism of action but in a soft bait presentation preferred over liquids by pest management professionals (‘PMPs’) and residential customers. SenesTech’s products are the first, and still the only, such rat contraceptives for both males and females registered with the U.S. Environmental Protection Agency (‘EPA’) designed to be non-lethal,” a recent article explains. “The company conducted…

Continue Reading

FridayMar 01, 2024 1:45 pm

NetworkNewsBreaks – DealFlow Events to Host Billionaire Investor at the Activist Investor Conference

DealFlow Events is preparing to host the Activist Investor Conference on March 21, 2024, in New York City, the premiere event where investors, corporate governance experts, advisory firms, proxy solicitors, and board members gather to gain insights and forge partnerships. Activist investor Nelson Peltz, locked in a proxy battle with The Walt Disney Company, will share his perspective with CNBC reporter Paulina Likos at the event. According to the announcement, Peltz oversees Trian Fund Management, which owns roughly $3 billion worth of Disney stock. He is pushing the corporation for seats on the Disney board for himself and former Disney…

Continue Reading

FridayMar 01, 2024 1:42 pm

NetworkNewsBreaks – Sidus Space Inc. (NASDAQ: SIDU) Announces $7.9M Public Offering

Sidus Space (NASDAQ: SIDU), a multifaceted space and data-as-a-service company, has announced the pricing of an underwritten public offering of 1,321,000 shares of its Class A common stock, which is expected to close on Mar. 5, 2024. The announcement noted that each share of Class A common stock is being sold at a public offering price of $6.00 per share for gross proceeds of approximately $7.9 million before deducting underwriting discounts and offering expenses. The company intends to use the net proceeds from the offering for working capital and general corporate purposes. ThinkEquity is acting as sole book-running manager for…

Continue Reading

FridayMar 01, 2024 12:58 pm

NetworkNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Appoints Raffi Sossoyan as New Chief Financial Officer

Vision Marine Technologies Inc. (NASDAQ: VMAR), a trailblazer in electric recreational boating, today announced Raffi Sossoyan as its new chief financial officer (“CFO”). Sossoyan brings a wealth of experience, with over 25 years in global financial and operational leadership. In his recent role as VP, corporate treasury at Velan Inc. (TSX: VLN), a Canadian multinational company, he managed financial operations amidst global sales exceeding US$370 million. According to the announcement, Sossoyan’s tenure as CFO at Valtech Fabrication Inc., where he drove worldwide sales beyond US$50 million, further highlights his capacity to spearhead financial growth and success. “This strategic appointment marks…

Continue Reading

FridayMar 01, 2024 12:12 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Cleared to Commence HYPER-H23-1 Clinical Trial

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that the U.S. Food and Drug Administration (“FDA”) has confirmed the effectiveness of the company’s investigational new drug (“IND”) application thereby clearing Lexaria to conduct its planned U.S. Phase 1b hypertension clinical trial HYPER-H23-1 utilizing DehydraTECH-CBD. According to the announcement, the company is pleased to have complied with the FDA’s rules and procedures for clearance to perform this important registrational trial. The company will further announce when it is ready to begin the study, subject to certain conditions, including raising sufficient funding. “This is a significant…

Continue Reading

FridayMar 01, 2024 12:11 pm

NetworkNewsBreaks – Mountain Top Properties Inc. (MTPP) to Tap into Resilient Hamptons’ Real Estate Market

Mountain Top Properties (OTC: MTPP) is a diversified real estate holding company focused on building, acquiring, marketing, and operating assets through its wholly owned affiliates. The company is looking to tap into the strength of the high-end real estate market in the Hamptons. “Despite a high interest rate environment, Hamptons-based real estate has shown remarkable resilience over the past year… Despite seeing a 26% decline in year-over-year sales of individual properties, homes priced between $1 million and $3.5 million – which have historically accounted for the lion share of Hamptons’ property transactions, only witnessed a 21% decline,” a recent article…

Continue Reading

ThursdayFeb 29, 2024 3:27 pm

NetworkNewsBreaks – Cboe Canada Collaborates to Launch New AGF ETF Series

Cboe Canada has announced the return of AGF Investments Inc. with the launch of ETF series of AGF Global Real Assets Fund (NEO: AGLR), AGF Total Return Bond Fund (NEO: ATRB) and AGF U.S. Small-Mid Cap Fund (NEO: ASMD) (the “AGF ETF Series”). The three new AGF ETF Series join seven AGF EFTs already listed on Cboe Canada. “We are pleased to partner with AGF Investments once again, as they continue to build out their product shelf and bring new investment mandates and further diversification to the market,” said Erik Sloane, chief revenue officer of Cboe Canada. “It is an honour…

Continue Reading